“…PURPOSE: The purpose of this study was to observe the morphologic characteristics of patent foramen ovale (PFO) by transesophageal echocardiography (TEE), and to analyze its correlation with right-to-left shunt (RLS) of contrast-transthoracic echocardiography (c-TTE) and contrast-transcranial Doppler ultrasonography (c-TCD). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…PURPOSE: The association of patent foreman ovale (PFO) and cryptogenic stroke has been studied for years. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Maintaining patent airways is vital in pediatric anesthetic management. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In the ACL repair group, three patients were lost to follow-up leaving 134 patents (97.8%) for the final analysis. Secondary surgery was identified by contacting the patients by email/telephone and reviewing patient notes at the time of this analysis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: A reconstructive challenge in patients with class IIId maxillary defect is how to obliterate the defect and restore a patent nasal airway. The current strategy using the single anterolateral thigh (ALT) fasciocutaneous flap for reconstruction may result in permanent mouth breathing. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Gene expression related to DNA repair was investigated in two independent cohorts of hospitalized Covid-19 patients (Cohort 1; 15 patents and 5 controls, Cohort 2; 15 patients and 6 controls), and by publicly available datasets. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Additionally, living near main roads was positively associated with secundum atrial septal defect/patent foramen ovale (aOR = 2.65, 95% CI = 1.03–6.81) and housing renovation was strongly positively associated with ventricular septal defect (aOR = 5.08, 95% CI = 2.05–12.60). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The extent of registration of multiple sourced versus new patented medicines was also explored. METHODS: A retrospective, descriptive and quantitative investigation was conducted for medicines registered between 2014 and 2019. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…NLDS was diagnosed by patent lacrimal syringing and combined dacryocystography (NLD stenosis) and dacryoscintigraphy (post-sac delay) findings in all eyes. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Maloney, MD, PhD, A2 Biotherapeutics (Consultant, Other Financial or Material Support, Stock Options)Bioline Rx (Consultant)Celgene (Consultant, Grant/Research Support)Gilead (Consultant)Juno Therapeutics (Consultant, Research Grant or Support, Other Financial or Material Support, four pending patents, not issued, licensed, no royalities, no licensees)Kite Pharma (Consultant, Grant/Research Support)Novartis (Consultant)Pharmacyclics (Consultant) Cameron J. …”
Enlace del recurso
Enlace del recurso

“…Porter:  ASH: Membership on an entity's Board of Directors or advisory committees; Incyte: Membership on an entity's Board of Directors or advisory committees; DeCart: Membership on an entity's Board of Directors or advisory committees; Genentech: Current equity holder in publicly-traded company, Ended employment in the past 24 months; American Society for Transplantation and Cellular Therapy: Honoraria; Kite/Gilead: Membership on an entity's Board of Directors or advisory committees; Janssen: Membership on an entity's Board of Directors or advisory committees; National Marrow Donor Program: Membership on an entity's Board of Directors or advisory committees; Novartis: Membership on an entity's Board of Directors or advisory committees, Patents & Royalties, Research Funding; Tmunity: Patents & Royalties; Wiley and Sons Publishing: Honoraria. …”
Enlace del recurso
Enlace del recurso

“…Amrolia:  ADC Therapeutics: Other: Named inventor on a patent which is being transferred to ADCT.; Autolus: Patents & Royalties.…”
Enlace del recurso
Enlace del recurso

“…We divided 955 grafts into the patent group and occluded group by CTA results. Logistic regression model at graft-level were established to determine predictors of the early asymptomatic graft occlusion. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In order to better benefit the majority of tinnitus patients, we developed a new mobile app based on our patented invention – named the Fudan Tinnitus Relieving System (FTRS) – for tinnitus management. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The relationship between sleep and early AD was examined using a patented sleep mattress designed to record respiration and high frequency movement arousals. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CKN is a ginsenoside compound K derivative that was previously reported to have excellent antiatherosclerotic activity in vitro, and we have applied for international patents for it. METHODS: Male C57BL/6 ApoE(−/−) mice were fed a high-fat and high-choline diet to induce atherosclerosis and were subjected to in vivo studies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Portal and hepatic veins were patent. Initial workup for viral, autoimmune-, toxin-, and medication-related hepatitis was negative. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Synchronous multimode ultrasound had a sensitivity of 87.5% and specificity of 60.6% in the patent foramen ovale (PFO) diagnosis. Binary logistic regression analyses showed that age (odds ratio [OR] = 1.041) and risk of paradoxical embolism score ≥ 7 (OR = 7.798) were risk factors for stroke recurrence, whereas antiplatelets (OR = 0.590) and PFO closure with antiplatelets (OR = 0.109) were protective factors. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…All magnets were successfully placed, expelled without re-intervention, and formed patent durable anastomoses. Total weight loss at 12 months was 34.0 ± 1.4% (SEM); excess weight loss, 80.2 ± 6.6%; and BMI reduction, 15.1. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Qiangli Dingxuan tablet (QDT) is a formally approved Chinese patent medicine, which has been widely used as an adjunctive treatment for hypertension. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso